Search Autoimmune Association

Explore Clinical Trials

Clinical trials offer early access to cutting-edge treatments that can lead to progress in research, improved treatment options, and better outcomes. Through clinical trials, researchers can better understand how to diagnose, treat, and prevent diseases or conditions, which brings us one step closer to a world without autoimmune disease.

PORTOLA

Autoimmune Hepatitis (AIH)

PORTOLA is a randomized, double-blind, placebo-controlled phase 2a study with an open-label extension to evaluate the safety and efficacy of zetomipzomib (KZR-616) in people living with autoimmune hepatitis (AIH). Zetomipzomib is a first-in-class, investigational product being studied for the treatment of autoimmune diseases, including autoimmune hepatitis, a rare and chronic autoimmune liver disease. Zetomipzomib acts by inhibiting the immunoproteasome, a structure found in immune cells that helps to regulate the normal functioning of the immune system.

Learn more

Current Clinical Trials

Browse current studies with filters that allow you to search by condition, treatment, location, and more.

ClinicalTrials.gov
CenterWatch
ResearchMatch